1. Home
  2. HITI vs CRBU Comparison

HITI vs CRBU Comparison

Compare HITI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.48

Market Cap

213.6M

Sector

N/A

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.29

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
CRBU
Founded
2009
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
179.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HITI
CRBU
Price
$2.48
$2.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$6.13
$10.75
AVG Volume (30 Days)
371.2K
1.2M
Earning Date
03-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.73
$1.63
Revenue Next Year
$12.80
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.73
52 Week High
$4.06
$3.53

Technical Indicators

Market Signals
Indicator
HITI
CRBU
Relative Strength Index (RSI) 59.64 66.85
Support Level $2.43 $1.70
Resistance Level $2.51 $2.66
Average True Range (ATR) 0.08 0.12
MACD 0.03 0.03
Stochastic Oscillator 91.06 93.45

Price Performance

Historical Comparison
HITI
CRBU

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: